MedPath

CONNECTA THERAPEUTICS S.L.

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Neural Biomarkers in Fragile X Syndrome

Completed
Conditions
Neurotypical Adults
Fragile X Syndrome (FXS)
First Posted Date
2025-05-04
Last Posted Date
2025-05-04
Lead Sponsor
Connecta Therapeutics, S.L.
Target Recruit Count
20
Registration Number
NCT06957054
Locations
🇪🇸

Consorci Corporació Sanitaria Parc Taulí. Institut Investigació i Innovació Parc Taulí (I3PT), Sabadell, Barcelona, Spain

🇪🇸

Hospital del Mar Research Institute (HMRI), Barcelona, Spain

CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

Phase 1
Completed
Conditions
Fragile X Syndrome
Interventions
Other: Placebo
First Posted Date
2024-07-01
Last Posted Date
2025-01-23
Lead Sponsor
Connecta Therapeutics, S.L.
Target Recruit Count
76
Registration Number
NCT06480968
Locations
🇪🇸

Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath